TheStreet

Log In

Receive full access to our market insights, commentary, newsletters, breaking news alerts, and more.
Forgot your password?Don't have an account? Sign Up Here

Join Us

Receive full access to our market insights, commentary, newsletters, breaking news alerts, and more.
Already have an account? Login here
TheStreet
JIM CRAMERINVESTINGPERSONAL FINANCERETIREMENTTECHNOLOGYMARKETSHOW-TOVIDEOFINANCIAL ADVISOR CENTER
Search

Trade with Jim Cramer 14 Days Free

Join the Action Alerts PLUS Community today!

SUBSCRIBE NOW

LATEST NEWS

Trader New York Stock Exchange Lead
MARKETS

Dow Futures, Apple, Nikola, FedEx - 5 Things You Must Know Tuesday

  • By Joseph Woelfel
  • Sep 15, 2020 7:18 AM EDT
PRESS RELEASES

WeissLaw LLP Reminds MR, IMMU, And BMCH Shareholders About Its Ongoing Investigations

  • By PR Newswire
  • Oct 2, 2020 8:55 PM EDT
PRESS RELEASES

WeissLaw LLP Reminds MR, IMMU, And BMCH Shareholders About Its Ongoing Investigations

  • By PR Newswire
  • Sep 25, 2020 10:55 PM EDT
PRESS RELEASES

SHAREHOLDER ALERT: WeissLaw LLP Reminds AKCA, IMMU, And MXIM Shareholders About Its Ongoing Investigations

  • By PR Newswire
  • Sep 25, 2020 10:35 PM EDT
PRESS RELEASES

(IMMU) Alert: Johnson Fistel Investigates Proposed Sale Of Immunomedics; Is $88 A Fair Price?

  • By PR Newswire
  • Sep 20, 2020 9:45 PM EDT
PRESS RELEASES

Moore Kuehn Encourages IMMU, ONDK, VRTU, And OTEL Investors To Contact Law Firm

  • By PR Newswire
  • Sep 15, 2020 1:51 PM EDT
PRESS RELEASES

ALERT: Halper Sadeh LLP Is Investigating The Following Mergers; Shareholders Are Encouraged To Contact The Firm

  • By PR Newswire
  • Sep 15, 2020 1:33 PM EDT
Trader New York Stock Exchange Lead
MARKETS

Dow Futures, Apple, Nikola, FedEx - 5 Things You Must Know Tuesday

  • By Joseph Woelfel
  • Sep 15, 2020 7:18 AM EDT
New York Stock Exchange Lead
JIM CRAMER

Still Undervalued: Cramer's 'Mad Money' Recap (Monday 9/14/20)

  • By Scott Rutt
  • Sep 14, 2020 9:00 PM EDT
PRESS RELEASES

SHAREHOLDER ALERT: WeissLaw LLP Investigates Immunomedics, Inc.

  • By PR Newswire
  • Sep 14, 2020 6:57 PM EDT
Activist Investor to Block Partnership of Immunomedics and Seattle Genetics
INVESTING

Immunomedics, Scientific Games: 5 Top Gainers for Monday

  • By Rob Lenihan
  • Sep 14, 2020 4:21 PM EDT
Midday Report: Stocks Turn Higher as Big Banks' Earnings Beat Wall Street's Expectations
MARKETS

Stocks Finish Higher on M&A News and Vaccine Progress

  • By Joseph Woelfel
  • Sep 14, 2020 4:17 PM EDT
PRESS RELEASES

IMMUNOMEDICS INVESTOR ALERT By The Former Attorney General Of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy Of Price And Process In Proposed Sale Of Immunomedics - IMMU

  • By Business Wire
  • Sep 14, 2020 2:57 PM EDT
Jim Cramer Reacts to the Gilead Sciences-Kite Pharma Acquisition
INVESTING

Buy Gilead on Immunomedics Deal? Let's Look at the Charts

  • By Bret Kenwell
  • Sep 14, 2020 2:45 PM EDT
Gilead-5f0876a85129505ee26e208e_Jul_10_2020_14_18_12
INVESTING

Gilead Sciences Agrees $21 Billion Takeover Of Cancer Drug Specialist Immunomedics

  • By Martin Baccardax
  • Sep 14, 2020 10:03 AM EDT
New York Stock Exchange Lead
INVESTING

Dow Futures Gain As AstraZeneca Resumes Coronavirus Vaccine Trials, Tech and Pharma Deals Boost Market Sentiment

  • By Martin Baccardax
  • Sep 14, 2020 8:51 AM EDT
Trader New York Stock Exchange Lead
MARKETS

TikTok Picks Oracle, Nvidia Buys Arm, Gilead Buys Immunomedics - 5 Things You Must Know Monday

  • By Joseph Woelfel
  • Sep 14, 2020 7:30 AM EDT
PRESS RELEASES

Immunomedics Merger Investigation: Halper Sadeh LLP Announces Investigation Into Whether The Sale Of Immunomedics, Inc. Is Fair To Shareholders; Investors Are Encouraged To Contact The Firm - IMMU

  • By Business Wire
  • Sep 13, 2020 10:00 PM EDT
PRESS RELEASES

Gilead Sciences To Acquire Immunomedics

  • By Business Wire
  • Sep 13, 2020 3:00 PM EDT
PRESS RELEASES

(IMMU) Alert: Shareholder Class Action Against Immunomedics Survives Motion To Dismiss; Should Management Be Held Accountable For Investors Losses? Contact Johnson Fistel

  • By PR Newswire
  • Aug 20, 2020 7:20 PM EDT
PRESS RELEASES

Shareholder Alert: Robbins LLP Announces It Is Investigating Immunomedics, Inc. (IMMU) For Misleading Shareholders

  • By Business Wire
  • Jun 29, 2020 4:25 PM EDT
PRESS RELEASES

Shareholder Alert: Robbins LLP Reminds Investors Shareholder Class Action Against Immunomedics, Inc. (IMMU) Survives Motion To Dismiss

  • By Business Wire
  • Jun 24, 2020 6:01 PM EDT
Pharmaceuticals Lead
INVESTING

Immunomedics Gets Double-Downgrade to Sell From Goldman Sachs

  • By Rob Lenihan
  • Apr 3, 2020 11:30 AM EDT
PRESS RELEASES

Immunomedics To Report Results For The Fourth Quarter And Full Year 2019 And Host Conference Call And Webcast On February 27, 2020

  • By GlobeNewswire
  • Feb 20, 2020 8:00 AM EST
PRESS RELEASES

Immunomedics Appoints Dr. Loretta Itri Chief Medical Officer

  • By GlobeNewswire
  • Feb 14, 2020 8:00 AM EST
TheStreet
  • Terms Of Use
  • Privacy Policy
  • Advertise
  • Reprints
  • Customer Service
  • Data
  • Topic Archive
  • Subscriptions
© 2021 TheStreet, Inc. All rights reserved. Action Alerts PLUS is a registered trademark of TheStreet, Inc.